Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”

BMC Urology

Commentary

Peter A Pinto¹  Adam R Metwalli¹ 

[1] Urologic Oncology Branch, National Cancer Institute, NIH, Building 10, Room 2W-5940, 10 Center Drive, MSC 1210, 2089s, Bethesda, MD, USA;

关键词: Prostate cancer;    Therapy;    Focal;    Cryoablation;    Image guided surgery;   

DOI  :  10.1186/1471-2490-13-39

 received in 2013-03-22, accepted in 2013-06-21,  发布年份 2013

来源: Springer

【 摘 要 】

The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being investigated. The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on: http://www.biomedcentral.com/1471-2490/13/2.

【 授权许可】

CC BY   
© Metwalli and Pinto; licensee BioMed Central Ltd. 2013